Abstract
This report concerns a clinical trial with Gd-DTPA as an intravenous contrast medium for MRI in patients with neurological disorders. 50 patients (30 female, 20 male) were examined without and with Gd-DTPA and the results of CT scanning and MR scanning without and with Gd-DTPA were compared. All patients tolerated the contrast medium very well. In the various patient groups, Gd-DTPA often added to the information. This was especially true in the tumor group, where better delineation of tumor, blood, and edema was obtained.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Claussen C, M Laniado, W Schörner, HP Niendorf, HJ Weinmann, W Fiegler, R Felix: Gadolinium-DTPA in MR imaging of glioblastoma and intracranial metastases. AJNR 6 (1985) 669–674
Claussen C, M Laniado, E Kazner, W Schörner, R Felix: Application of contrast agents in CT and MRI (NMR): their potential in imaging of brain tumors. Neuroradiology 27 (1985) 164–171
Curati WL, M Graif, DPE Kingsley, HP Niendorf, IR Young: Acoustic neurinomas: Gd-DTPA enhancement in MR imaging. Radiology 158 (1986) 447–451
Felix R, W Schörner, M Laniado, HP Niendorf, C Claussen, W Fiegler, U Speck: Brain tumors: MR imaging with Gadolinium-DTPA. Radiology 156 (1985) 681–688
Runge VM, JA Clanton, AC Price, WA Herzer, JH Allen, CL Partain, AE James Jr.: Evaluation of contrast-enhanced MR imaging in a brain-abscess model. AJNR 6 (1985) 139–147
Semmler W, R Felix: Kontraste in der Kernspintomographie. Fortschr Röntgenstr 141 (1984) 259–267
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Valk, J., De Slegte, R.G.M., Crezee, F.C. et al. Gadolinium — DTPA in magnetic resonance imaging of the brain. Neurosurg. Rev. 10, 87–92 (1987). https://doi.org/10.1007/BF01741443
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01741443